Given the fact that IL-6 is clearly implicated in inflammatory bowel disease and other chronic diseases and cancer, its serum levels are considered markers of inflammatory diseases and anti-IL-6 treatments are under investigation [35]. This evidence concerns the gene IL6 and inflammatory bowel disease.